ES2357354T3 - Micelas híbridas de copolímero en bloque con estereoquímica mixta para encapsulación de agentes hidrófobos. - Google Patents

Micelas híbridas de copolímero en bloque con estereoquímica mixta para encapsulación de agentes hidrófobos. Download PDF

Info

Publication number
ES2357354T3
ES2357354T3 ES08747201T ES08747201T ES2357354T3 ES 2357354 T3 ES2357354 T3 ES 2357354T3 ES 08747201 T ES08747201 T ES 08747201T ES 08747201 T ES08747201 T ES 08747201T ES 2357354 T3 ES2357354 T3 ES 2357354T3
Authority
ES
Spain
Prior art keywords
micellas
encapsulation
block
hydrophobic agents
hybrid copolymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES08747201T
Other languages
English (en)
Inventor
Kevin N. Sill
Habib Skaff
Kurt Breitenkamp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intezyne Technologies Inc
Original Assignee
Intezyne Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intezyne Technologies Inc filed Critical Intezyne Technologies Inc
Application granted granted Critical
Publication of ES2357354T3 publication Critical patent/ES2357354T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/08Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/04Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers only
    • C08G65/06Cyclic ethers having no atoms other than carbon and hydrogen outside the ring
    • C08G65/08Saturated oxiranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/26Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds
    • C08G65/2618Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing nitrogen
    • C08G65/2621Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing nitrogen containing amine groups
    • C08G65/2627Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing nitrogen containing amine groups containing aromatic or arylaliphatic amine groups
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/321Polymers modified by chemical after-treatment with inorganic compounds
    • C08G65/325Polymers modified by chemical after-treatment with inorganic compounds containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • C08G65/333Polymers modified by chemical after-treatment with organic compounds containing nitrogen
    • C08G65/33331Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing imide group
    • C08G65/33337Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing imide group cyclic
    • C08G65/33341Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing imide group cyclic aromatic
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/08Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
    • C08G69/10Alpha-amino-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02Polyamines
    • C08G73/028Polyamidoamines
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/02Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2261/00Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
    • C08G2261/10Definition of the polymer structure
    • C08G2261/12Copolymers
    • C08G2261/126Copolymers block
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2377/00Characterised by the use of polyamides obtained by reactions forming a carboxylic amide link in the main chain; Derivatives of such polymers
    • C08J2377/04Polyamides derived from alpha-amino carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00Applications
    • C08L2203/02Applications for biomedical use
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/29Polyamino acid or polypeptide with an uninterrupted series of peptide repeating units
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/70Nanostructure
    • Y10S977/773Nanoparticle, i.e. structure having three dimensions of 100 nm or less
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/902Specified use of nanostructure
    • Y10S977/904Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906Drug delivery

Abstract

Una micela que comprende un copolímero en múltiples bloques que contiene un bloque hidrofílico polimérico, opcionalmente un poli(bloque de aminoácido) entrecruzado o entrecruzable, y un bloque de poli(aminoácido) mixto D,L hidrófobo, en donde dicha micela tiene un núcleo interno, opcionalmente un núcleo externo entrecruzado o entrecruzable, y una capa hidrofílica, en donde el copolímero en múltiples bloques es de fórmula I en donde: n es 10 - 2500; m es 0 a 1000; m' es 2 a 1000; R x es un grupo de cadena lateral de aminoácido natural o no natural que es capaz de entrecruzamiento; R y forma un bloque de poli(aminoácido) mixto D,L hidrófobo; R 1 es -Z(CH2CH2Y)p(CH2)tR 3 , en donde: Z es -O-, -S-, -C≡C-, o -CH2-; cada Y es independientemente -O- o -S-; p es 0 - 10; t es 0 - 10; y R 3 es hidrógeno, -N3, -CN, una amina monoprotegida, una amina diprotegida, un aldehído protegido, un hidroxilo protegido, un ácido carboxílico protegido, un tiol protegido, un éter corona de 9 - 30 miembros, o un grupo opcionalmente sustituido seleccionado de alifático, un anillo saturado, parcialmente insaturado de 5 - 8 miembros, o anillo arilo que tiene 0 - 4 heteroátomos independientemente seleccionados a partir de nitrógeno, oxígeno, o azufre, un anillo saturado, parcialmente insaturado de 8 - 10 miembros, o un anillo arilo bicíclico que tiene 0 - 5 heteroátomos independientemente seleccionado a partir de nitrógeno, oxígeno, o azufre, o una fracción detectable; Q es un enlace de valencia o una cadena hidrocarbonada C1 - 12 de cadena recta o ramificada, saturada o insaturada, bivalente, en donde 0 - 6 unidades de metileno de Q son independientemente reemplazadas por -Cy-, -O-, -NH-, -S-, -OC(O)-, -C(O)O-, -C(O)-, -SO-, -SO2-, -NHSO2-, -SO2NH-, -NHC(O)-, -C(O)NH-, ­ OC(O)NH-, o -NHC(O)O-, en donde: -Cy- es un anillo saturado, parcialmente insaturado, bivalente de 5 - 8 miembros opcionalmente sustituido, o anillo arilo que tiene 0 - 4 heteroátomos independientemente seleccionados a partir de nitrógeno, oxígeno, o azufre, o un anillo saturado, parcialmente insaturado, bivalente de 8 - 10 miembros opcionalmente sustituido, o anillo arilo bicíclico que tiene 0 - 5 heteroátomos independientemente seleccionados a partir de nitrógeno, oxígeno, o azufre; R 2a es una amina monoprotegida, una amina diprotegida, -N(R 4 )2, -NR 4 C(O)R 4 , -NR 4 C(O)N(R 4 )2, -NR 4 C(O)OR 4 , o -NR 4 SO2R 4 ; y cada R 4 es independientemente hidrógeno o un grupo opcionalmente sustituido seleccionado a partir de alifático, un anillo parcialmente insaturado, saturado de 5 - 8 miembros, o anillo arilo que tiene 0 - 4 heteroátomos independientemente seleccionados a partir de nitrógeno, oxígeno, o azufre, un anillo saturado, parcialmente insaturado, de 8 - 10 miembros, o anillo arilo bicíclico que tiene 0 - 5 heteroátomos independientemente seleccionados a partir de nitrógeno, oxígeno, o azufre, o una fracción detectable, o: se toman dos R 4 sobre el mismo átomo de nitrógeno junto con dicho átomo de nitrógeno para formar un anillo saturado, parcialmente insaturado, de 4 - 7 miembros, opcionalmente sustituido, o anillo arilo que tiene 1 - 4 heteroátomos independientemente seleccionados a partir de nitrógeno, oxígeno, o azufre, caracterizada porque R y consiste de una mezcla de una mezcla de grupos de cadena lateral de aminoácido Lhidrofílico y D-hidrófobo de tal manera que el bloque completo de poli(aminoácido) que comprende R y es hidrófobo
ES08747201T 2007-04-30 2008-04-30 Micelas híbridas de copolímero en bloque con estereoquímica mixta para encapsulación de agentes hidrófobos. Active ES2357354T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91495807P 2007-04-30 2007-04-30
US914958P 2007-04-30

Publications (1)

Publication Number Publication Date
ES2357354T3 true ES2357354T3 (es) 2011-04-25

Family

ID=39586942

Family Applications (2)

Application Number Title Priority Date Filing Date
ES10013947T Active ES2432641T3 (es) 2007-04-30 2008-04-30 Micelas híbridas de copolímero en bloque con estereoquímica mixta para encapsulación de agentes hidrófobos
ES08747201T Active ES2357354T3 (es) 2007-04-30 2008-04-30 Micelas híbridas de copolímero en bloque con estereoquímica mixta para encapsulación de agentes hidrófobos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES10013947T Active ES2432641T3 (es) 2007-04-30 2008-04-30 Micelas híbridas de copolímero en bloque con estereoquímica mixta para encapsulación de agentes hidrófobos

Country Status (13)

Country Link
US (3) US7799339B2 (es)
EP (2) EP2359862B1 (es)
JP (2) JP5403826B2 (es)
KR (1) KR101697363B1 (es)
AT (1) ATE485840T1 (es)
AU (1) AU2008245404B2 (es)
CA (1) CA2685350C (es)
DE (1) DE602008003183D1 (es)
ES (2) ES2432641T3 (es)
IL (1) IL201839A (es)
MX (1) MX2009011479A (es)
NZ (2) NZ580605A (es)
WO (1) WO2008134731A1 (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2861601A1 (en) * 2006-04-27 2007-11-08 Intezyne Technologies, Inc. Poly (ethylene glycol) containing chemically disparate endgroups
NZ580605A (en) * 2007-04-30 2012-05-25 Intezyne Technologies Inc Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents
WO2008134734A2 (en) * 2007-04-30 2008-11-06 Intezyne Technologies, Inc. Encapsulated contrast agents
US20100311903A1 (en) * 2007-11-07 2010-12-09 Raghavan Rajagopalan Photonic Shell-Core Cross Linked and Functionalized Nanostructures for Biological Applications
CA2722767A1 (en) * 2008-04-30 2009-11-05 Kevin N. Sill Synthesis of hybrid block copolymers from difluoroacetate ammonium salts
CN101869712B (zh) * 2009-04-21 2016-01-20 财团法人工业技术研究院 使用包囊抗肿瘤药物的聚合胶束用于治疗肿瘤的药物组合物
GB0907251D0 (en) * 2009-04-28 2009-06-10 Univ Leiden Coplymers
WO2010127271A1 (en) 2009-04-30 2010-11-04 Intezyne Technologies, Incorporated Polymer micelles containing anthracylines for the treatment of cancer
US8524784B2 (en) 2009-04-30 2013-09-03 Intezyne Technologies, Incorporated Polymer micelles containing anthracylines for the treatment of cancer
KR20120094546A (ko) * 2009-05-04 2012-08-24 인터자인 테크놀로지스, 인코포레이티드 종양 치료를 위한 sn―38을 함유하는 폴리머 미셀
CN103002921A (zh) 2010-05-14 2013-03-27 马林克罗特有限公司 用于联合的光学成像和治疗的功能性交联纳米结构
EP2609935B1 (en) * 2010-08-23 2018-10-10 Shimadzu Corporation Switching fluorescent nanoparticle probe and fluorescent particle imaging method using same
WO2012058552A1 (en) * 2010-10-29 2012-05-03 Intezyne Technologies, Incorporated Iron stabilized polymer micelles for drug delivery applications
WO2012097133A2 (en) * 2011-01-12 2012-07-19 H. Lee Moffitt Cancer Center And Research Institute, Inc. Compounds and methods for inducing apoptosis in cancer cells using a bh3 alpha-helical mimetic
GB2488788B (en) * 2011-03-07 2013-07-10 Natco Pharma Ltd Oral formulation of phenylaminopyrymidine compound with enhanced bioavailability and pharmacological response
EP2683410A2 (en) * 2011-03-08 2014-01-15 Access Pharmaceuticals, Inc. Targeted nanocarrier systems for delivery of actives across biological membranes
EP2714023A4 (en) * 2011-05-23 2014-12-24 Univ Massachusetts RETICULATED POLYMER NANO-ASSEMBLIES AND USES THEREOF
US8609146B2 (en) 2011-09-19 2013-12-17 Intezyne Technologies, Inc. Multi-block copolymers for the preparation of stabilized micelles
CN102408561B (zh) * 2011-11-14 2013-03-27 中国科学院长春应用化学研究所 一种嵌段共聚物、其制备方法及温度敏感型水凝胶
WO2013151537A1 (en) * 2012-04-03 2013-10-10 Empire Technology Development Llc Biocompatible adhesive polymers
US20140113879A1 (en) * 2012-04-11 2014-04-24 Intezyne Technologies, Inc. Block copolymers for stable micelles
WO2013154774A1 (en) 2012-04-11 2013-10-17 Intezyne Technologies, Inc. Block copolymers for stable micelles
AU2016250403B2 (en) * 2012-04-11 2018-12-06 Intezyne Technologies, Inc Block copolymers for stable micelles
AU2014256366B2 (en) * 2012-04-11 2016-12-08 Intezyne Technologies, Inc. Block copolymers for stable micelles
US20140114051A1 (en) * 2012-04-11 2014-04-24 Intezyne Technologies, Inc. Block copolymers for stable micelles
US9944752B2 (en) 2012-04-11 2018-04-17 Intezyne Technologies, Inc. Block copolymers for stable micelles
US20140127271A1 (en) * 2012-04-11 2014-05-08 Intezyne Technologies, Inc. Block copolymers for stable micelles
US10137081B2 (en) 2012-09-28 2018-11-27 Delpor, Inc. Device and method for sustained release of antipsychotic medications
TWI454450B (zh) 2012-11-02 2014-10-01 Ind Tech Res Inst 有機化合物及包含其之有機電激發光裝置
CN103304802B (zh) * 2013-05-28 2015-04-22 上海交通大学 酸敏感两亲性嵌段共聚物及其制备、用途
US20160129117A1 (en) * 2013-07-03 2016-05-12 Nippon Kayaku Kabushiki Kaisha Novel Boronic Acid Compound Preparation
CN103709410B (zh) * 2013-12-03 2016-04-13 上海交通大学 酸敏感两亲性嵌段共聚物及其自组织胶束、用途
CN104856952B (zh) * 2015-05-13 2017-08-04 江南大学 一种聚(L‑谷氨酸)‑b‑聚乙二醇载药纳米胶束的制备
JPWO2017043653A1 (ja) * 2015-09-11 2018-06-28 国立大学法人 東京大学 タンパク質を安定化するための化合物
WO2018148432A1 (en) 2017-02-08 2018-08-16 Intezyne Technologies, Inc. Sn-38 loaded iron crosslinked micelle and methods thereof
CN107224589B (zh) * 2017-05-08 2021-03-26 中山大学 一种输送抗体用于肿瘤免疫治疗的mr成像聚合物胶束及其制备方法
CN108376608B (zh) * 2018-02-10 2020-11-06 青岛大学 一种磁性纳米粒子及其制备磁性固相载体的用途
US20210253543A1 (en) * 2018-09-28 2021-08-19 Lonza Ltd Method for preparation of n-carboxyanhydrides
CN109044972A (zh) * 2018-10-25 2018-12-21 宁夏医科大学 共载紫杉醇的辣椒素前药聚合物胶束及其制备方法
CR20220373A (es) * 2020-01-10 2022-11-23 Tyndall Formulation Services Llc Excipientes poliméricos para aplicaciones de administración de fármacos
WO2021142202A1 (en) 2020-01-10 2021-07-15 R-Pharm Us Operating Llc Compositions of ixabepilone
WO2021141605A1 (en) * 2020-01-10 2021-07-15 Tyndall Formulation Services, LLC Formulations of paclitaxel with poly(amino acid) block polymers
US10918619B1 (en) 2020-01-10 2021-02-16 Tyndall Formulation Services, LLC Formulations of paclitaxel with poly(amino acid) block polymers
US10836869B1 (en) 2020-01-10 2020-11-17 Tyndall Formulation Services, LLC Polymer excipients for drug delivery applications
US11286344B2 (en) 2020-01-10 2022-03-29 Tyndall Formulation Services, LLC Polymer excipients for drug delivery applications
US11857630B2 (en) 2020-01-10 2024-01-02 Tyndall Formulation Services, LLC Formulations of SN-38 with poly(amino acid) block polymers
KR102219317B1 (ko) * 2020-10-06 2021-02-24 엘앤피코스메틱 (주) 천연 보습인자를 이용하여 형성된 미셀 복합체를 포함하는 화장료 조성물의 제조방법 및 이로부터 제조된 화장료 조성물

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650270A (en) 1982-02-01 1997-07-22 Northeastern University Molecular analytical release tags and their use in chemical analysis
US4709016A (en) * 1982-02-01 1987-11-24 Northeastern University Molecular analytical release tags and their use in chemical analysis
US4650750A (en) * 1982-02-01 1987-03-17 Giese Roger W Method of chemical analysis employing molecular release tag compounds
US5516931A (en) * 1982-02-01 1996-05-14 Northeastern University Release tag compounds producing ketone signal groups
KR940003548U (ko) * 1992-08-14 1994-02-21 김형술 세탁물 건조기
WO2002026241A1 (fr) 2000-09-26 2002-04-04 Center For Advanced Science And Technology Incubation, Ltd. Micelle polymere renfermant du cisplatine et utilisation
JP2003267876A (ja) * 2002-03-15 2003-09-25 Nippon Kayaku Co Ltd 新規な血管狭窄治療剤又は予防剤
JP4535229B2 (ja) * 2003-05-08 2010-09-01 国立大学法人 東京大学 ポリエチレングリコール−ポリカチオンブロック共重合体
JP4920593B2 (ja) * 2004-10-25 2012-04-18 インテザイン テクノロジーズ, インコーポレイテッド ヘテロ二官能性ポリ(エチレングリコール)およびそれらの使用
MX2007008195A (es) * 2005-01-04 2008-02-22 Intezyne Technologies Llc Sintesis de copolimeros de bloque hibridos y usos de los mismos.
WO2006086325A2 (en) * 2005-02-11 2006-08-17 Intezyne Technologies, Incorporated Synthesis of homopolymers and block copolymers
ES2332062T3 (es) * 2005-04-01 2010-01-25 Intezyne Technologies Incorporated Micelas polimericas para el suministro de farmacos.
RU2008117425A (ru) * 2005-10-05 2009-11-10 Токио Кро, Инк. (Jp) Биосовместимый блоксополимер, его применение и способ его получения
CA2861601A1 (en) * 2006-04-27 2007-11-08 Intezyne Technologies, Inc. Poly (ethylene glycol) containing chemically disparate endgroups
NZ580605A (en) * 2007-04-30 2012-05-25 Intezyne Technologies Inc Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents

Also Published As

Publication number Publication date
JP2013199657A (ja) 2013-10-03
NZ580605A (en) 2012-05-25
ES2432641T3 (es) 2013-12-04
AU2008245404B2 (en) 2013-12-05
AU2008245404A1 (en) 2008-11-06
DE602008003183D1 (de) 2010-12-09
EP2359862A1 (en) 2011-08-24
JP5403826B2 (ja) 2014-01-29
KR101697363B1 (ko) 2017-01-17
CA2685350C (en) 2013-10-15
US20150232616A1 (en) 2015-08-20
NZ599523A (en) 2013-10-25
US7799339B2 (en) 2010-09-21
US20080274173A1 (en) 2008-11-06
WO2008134731A1 (en) 2008-11-06
US8980326B2 (en) 2015-03-17
JP2010526183A (ja) 2010-07-29
IL201839A0 (en) 2010-06-16
EP2073850A1 (en) 2009-07-01
ATE485840T1 (de) 2010-11-15
EP2073850B1 (en) 2010-10-27
MX2009011479A (es) 2010-02-01
IL201839A (en) 2014-05-28
CA2685350A1 (en) 2008-11-06
EP2359862B1 (en) 2013-07-24
US20100324259A1 (en) 2010-12-23
KR20100022000A (ko) 2010-02-26

Similar Documents

Publication Publication Date Title
ES2357354T3 (es) Micelas híbridas de copolímero en bloque con estereoquímica mixta para encapsulación de agentes hidrófobos.
MX2007012157A (es) Micelas polimericas para suministro de farmacos.
MX2007008195A (es) Sintesis de copolimeros de bloque hibridos y usos de los mismos.
MX2012001116A (es) Composiciones de copolimero hibrido para aplicaciones de cuidado personal.
EA201200951A1 (ru) Определенные триазолопиридины и триазолопиразины, их композиции и способы их применения
TW200641025A (en) Reverse phase hydrophilic polymers and their use in water-expandandable elastomeric compositions
WO2007130841A3 (en) Oral compositions comprising siloxane polymers
EA201171480A1 (ru) Полимерные соединения-иммуномодулирующие средства
MY162136A (en) Activin-actrii antagonists and uses for treating anemia
WO2007136552A3 (en) Compatibilized polymer processing additives
BRPI0719499A8 (pt) Composição de poliolefina funcional
WO2010127159A3 (en) Polymeric micelles for polynucleotide encapsulation
WO2010111576A3 (en) Aminated polymers and their use in water-borne compositions
MY164607A (en) Solid compositions
ATE489450T1 (de) Ophthalmischen zusammensetzungen enthaltend peo- pbo-blockcopolymeren
WO2009158015A3 (en) Antagonists of actriib and uses for increasing red blood cell levels
WO2007077561A3 (en) Compositions and methods for enhancing in-vivo uptake of pharmaceutical agents
BRPI0920836A2 (pt) composições de látex e de borracha de copolímero de nitrola, e, produto reticulado de borracha
EP2155794A4 (en) SOFT AND SOLID ELASTOMER COMPOSITIONS OF PARTIAL CRYSTALLINE AMORPHY POLYOLEFIN BLOCK COPOLYMERS
EA201390260A1 (ru) Композиция для ухода за волосами
WO2008157697A3 (en) Copolymer assay
BR112013008368A2 (pt) composição de polímero
WO2011082067A3 (en) Perfluoropolyether-containing compounds with oxalylamino groups
MX351330B (es) Hilo dental elastomerico.
EA201290666A1 (ru) Стабилизированная полипропиленовая композиция, обладающая улучшенными свойствами срока службы и старения